On the research front, Siemens Healthineers global research partners’ network expands across more than 2,400 research collaboration institutions worldwide enabling development and integration of pioneering innovations around technologies such as patient twinning, AI algorithm-development, advanced visualization techniques and postprocessing protocols improving patient care pathways particularly in Neurology, Cardiology and Oncology. Moreover, Innovation Think Tank’s (ITT) global presence spans multiple innovation labs and programs across more than 90 activity locations across hospitals, universities and government institutions. These partnerships with key healthcare institutions will focus on creating self-innovating infrastructures and precise product portfolio development for fostering entrepreneurship and commercialization.
"With a legacy of over 30 years as a global leader in AI patent applications in medical imaging and an impressive portfolio of over 1100 active patents related to machine learning, Siemens Healthineers is strategically positioned to guide clients towards a seamless integration of AI into clinical routines through our Regional Headquarters,” added Eng. Mohammad Ghazi, Managing Director of Siemens Healthineers' Regional Headquarters in Saudi Arabia
At Siemens Healthineers, we are guided by our purpose to pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Our uniqueness in patient twinning, precision therapy, digitalization, data and AI, enable us to contribute to the healthcare transformation initiatives in the Kingdom of Saudi Arabia and to address the challenges of non-communicable diseases, staff shortages, and inequitable healthcare access through our technologies and digital health solutions.
Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2023, which ended on September 30, 2023, Siemens Healthineers had approximately 71,000 employees worldwide and generated revenue of around €21.7 billion. Further information is available at www.siemens-healthineers.com.